Dr Gillies O’Bryan-Tear joins Clarity Pharmaceuticals’ Advisory Board
Sydney, Australia 23 August 2018 – Clarity Pharmaceuticals, an Australian radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that Dr Gillies O’Bryan-Tear has joined their scientific advisory board. Dr O’Bryan-Tear joined the pharmaceutical industry in 1986 where he has spent 30 years in clinical development, medical management and commercial roles.…